SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001095435-14-000064
Filing Date
2014-07-31
Accepted
2014-07-30 19:09:21
Documents
10
Period of Report
2014-07-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT pf2014.htm 20-F 628779
2 FINANCIAL STATEMENTS portagefinancials.htm EX-1 405219
3 COMPONSATION MATTERS compensationmatters.htm EX-11.1 36246
4 AUDIT MATTERS auditmatters.htm EX-11.2 53810
5 CODE OF CONDUCT codeconduct.htm EX-11.3 8491
6 EXHIBIT 12.1 CEO ceo.htm EX-12.1 20435
7 EXHIBIT 12.2 CFO cfo.htm EX-12.2 17082
8 EXHIBIT 13.1 CEO ceoexhibit.htm EX-13.1 5540
9 EXHIBIT 13.2 CFO cfoexhibit.htm EX-13.2 5390
10 flowchart2014.jpg GRAPHIC 75848
  Complete submission text file 0001095435-14-000064.txt   1286820
Mailing Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3
Business Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3 416-929-1806
PORTAGE BIOTECH INC. (Filer) CIK: 0001095435 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 20-F | Act: 34 | File No.: 000-30314 | Film No.: 141004115
SIC: 1311 Crude Petroleum & Natural Gas